The MiCardia Corporation of Irvine, California has announced the completion of the first U.S. implant of its Dynaplasty mitral valve repair technology.
MiCardia is developing Dynaplasty® technology for the treatment of structural heart disease, focusing initially on mitral and tricuspid valve disorders and as a method of interrupting a major element in the onset and progression of Heart Failure.
ebsteins.org helps train heart surgeon in new Ebsteins technique
Ebsteins.org has part funded leading Ebstein’s Anomaly heart surgeon Massimo Caputo to go to Brazil and spend 5 days with Dr Da Silva, the eminent cardiologist who pioneered the ‘cone surgery’ techniques (see here for Illustrations of Da Silvas cone technique). During the 5 days Massimo watched 5 different Ebstein’s operations, all very different and he looks forward to putting these into practice in the UK.
See more about .
We’re pleased that The Ebsteins Society is two years old and we’re going from strength to strength!
Just two years ago, Caroline and Tim launched www.ebsteins.org to the world and since then we’ve grown to a fully fledged charity and arguably the leading source of information and support for those affected by Ebsteins Anomaly. We’ve had a huge impact due to your support, postings, comments, and help. Here are some of our acheivements so far:
- Coordination and part-funding of bringing expertise on the cone technique to the UK
- Better understanding of the cone technique to several UK heart surgeons
- Raising of thousands of pounds to enable our work
- Worldwide, multi-lingual support forum sharing experiences
- Over 2,500 page hits per month and rising
- 306 members